2023 annual financial data
Zenas BioPharma 2023 Operating margin
Direct answer
Operating margin was -74.29%.
Operating income was -37,147,000 USD and net income was -37,124,000 USD.
Operating cash flow was -30,529,000 USD.
Get free Zenas BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,000,000 USD
- Operating income
- -37,147,000 USD
- Net income
- -37,124,000 USD
- Operating cash flow
- -30,529,000 USD